IDEXX Laboratories's operating cash flow per share for the
three
months ended in Dec. 2023 was $2.98.
IDEXX Laboratories's operating cash flow per share for the trailing twelve months (TTM) ended in Dec. 2023 was $10.80.
During the past 12 months, the average Operating Cash Flow per Share Growth Rate of IDEXX Laboratories was 68.20% per year.
During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 13.00% per year.
During the past 5 years, the average Operating Cash Flow per Share Growth Rate was 15.70% per year.
During the past 10 years, the average Operating Cash Flow per Share Growth Rate was 17.10% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.
The historical rank and industry rank for IDEXX Laboratories's Operating Cash Flow per Share or its related term are showing as below:
IDXX'
s 3-Year OCF Growth Rate Range Over the Past 10 Years
Min: -6.8 Med: 16.3 Max: 86.5
Current: 13
During the past 13 years, IDEXX Laboratories's highest 3-Year average Operating Cash Flow per Share Growth Rate was 86.50% per year. The lowest was -6.80% per year. And the median was 16.30% per year.
IDXX's 3-Year OCF Growth Rate is ranked better than 66.67% of 174
companies
in the Medical Diagnostics & Research industry
Industry Median: 2.05
vs IDXX: 13.00
IDEXX Laboratories Operating Cash Flow per Share Historical Data
The historical data trend for IDEXX Laboratories's Operating Cash Flow per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Premium members only.
IDEXX Laboratories Annual Data
Trend
Dec14
Dec15
Dec16
Dec17
Dec18
Dec19
Dec20
Dec21
Dec22
Dec23
Operating Cash Flow per Share
5.25
7.47
8.73
6.42
10.80
IDEXX Laboratories Quarterly Data
Mar19
Jun19
Sep19
Dec19
Mar20
Jun20
Sep20
Dec20
Mar21
Jun21
Sep21
Dec21
Mar22
Jun22
Sep22
Dec22
Mar23
Jun23
Sep23
Dec23
Operating Cash Flow per Share
2.07
2.19
2.39
3.24
2.98
Competitive Comparison
For the Diagnostics & Research subindustry, IDEXX Laboratories's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
IDEXX Laboratories Price-to-Operating-Cash-Flow Distribution
For the Medical Diagnostics & Research industry and Healthcare sector, IDEXX Laboratories's Price-to-Operating-Cash-Flow distribution charts can be found below:
* The bar in red indicates where IDEXX Laboratories's Price-to-Operating-Cash-Flow falls into.
IDEXX Laboratories Operating Cash Flow per Share Calculation
Operating Cash Flow per Share is the amount of Cash Flow from Operations per outstanding share of the company's stock.
IDEXX Laboratories's Operating Cash Flow per Share for the fiscal year that ended in Dec. 2023 is calculated as
Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $10.80
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
IDEXX Laboratories Operating Cash Flow per Share Related Terms
Thank you for viewing the detailed overview of IDEXX Laboratories's Operating Cash Flow per Share provided by GuruFocus.com. Please click on the following links to see related term pages.
IDEXX Laboratories (IDEXX Laboratories) Business Description
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets close to 40% of its revenue from outside the United States.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
IDXX has been successfully added to your 